Malignant Transformation of a Rosette-Forming Glioneuronal Tumor with IDH1 Mutation: A Case Report and Literature Review
Background: Rosette-forming glioneuronal tumor (World Health Organization grade I) is considered as a benign tumor with very low potential for progression. The potential for malignant transformation of this tumor is not known and has never been reported before in literature. Case Description: We rep...
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2019-04-01
|
Series: | World Neurosurgery: X |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2590139718300061 |
id |
doaj-39cd3f59f57a4e28bbb8ef0488e9277d |
---|---|
record_format |
Article |
spelling |
doaj-39cd3f59f57a4e28bbb8ef0488e9277d2020-11-25T02:13:00ZengElsevierWorld Neurosurgery: X2590-13972019-04-012Malignant Transformation of a Rosette-Forming Glioneuronal Tumor with IDH1 Mutation: A Case Report and Literature ReviewRonie Romelean Jayapalan0Kein Seong Mun1Kum Thong Wong2Sheau Fung Sia3Division of Neurosurgery, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia; To whom correspondence should be addressed: Ronie Romelean Jayapalan, M.B.B.S., M.R.C.S.Department of Pathology, Faculty of Medicine, University of Malaya, Kuala Lumpur, MalaysiaDepartment of Pathology, Faculty of Medicine, University of Malaya, Kuala Lumpur, MalaysiaDivision of Neurosurgery, Faculty of Medicine, University of Malaya, Kuala Lumpur, MalaysiaBackground: Rosette-forming glioneuronal tumor (World Health Organization grade I) is considered as a benign tumor with very low potential for progression. The potential for malignant transformation of this tumor is not known and has never been reported before in literature. Case Description: We report a 42-year-old man, diagnosed with rosette-forming glioneuronal tumor of the fourth ventricle with a positive isocitrate dehydrogenase 1 mutation, progressed to glioblastoma after 6 years from diagnosis. We discuss the clinical history, radiological findings, and histopathological characteristic with immunohistochemistry findings observed in this unique case. Conclusions: Despite being acceptable as benign, based on our observations in this case, there is a potential for malignant transformation of rosette-forming glioneuronal tumor. The role of isocitrate dehydrogenase 1 mutation leading to malignant transformation could not be established as our finding is novel and further prospective studies are required to prove this association. Key words: Glioblastoma IDH mutant, IDH 1 mutation, Malignant transformation, RGNThttp://www.sciencedirect.com/science/article/pii/S2590139718300061 |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Ronie Romelean Jayapalan Kein Seong Mun Kum Thong Wong Sheau Fung Sia |
spellingShingle |
Ronie Romelean Jayapalan Kein Seong Mun Kum Thong Wong Sheau Fung Sia Malignant Transformation of a Rosette-Forming Glioneuronal Tumor with IDH1 Mutation: A Case Report and Literature Review World Neurosurgery: X |
author_facet |
Ronie Romelean Jayapalan Kein Seong Mun Kum Thong Wong Sheau Fung Sia |
author_sort |
Ronie Romelean Jayapalan |
title |
Malignant Transformation of a Rosette-Forming Glioneuronal Tumor with IDH1 Mutation: A Case Report and Literature Review |
title_short |
Malignant Transformation of a Rosette-Forming Glioneuronal Tumor with IDH1 Mutation: A Case Report and Literature Review |
title_full |
Malignant Transformation of a Rosette-Forming Glioneuronal Tumor with IDH1 Mutation: A Case Report and Literature Review |
title_fullStr |
Malignant Transformation of a Rosette-Forming Glioneuronal Tumor with IDH1 Mutation: A Case Report and Literature Review |
title_full_unstemmed |
Malignant Transformation of a Rosette-Forming Glioneuronal Tumor with IDH1 Mutation: A Case Report and Literature Review |
title_sort |
malignant transformation of a rosette-forming glioneuronal tumor with idh1 mutation: a case report and literature review |
publisher |
Elsevier |
series |
World Neurosurgery: X |
issn |
2590-1397 |
publishDate |
2019-04-01 |
description |
Background: Rosette-forming glioneuronal tumor (World Health Organization grade I) is considered as a benign tumor with very low potential for progression. The potential for malignant transformation of this tumor is not known and has never been reported before in literature. Case Description: We report a 42-year-old man, diagnosed with rosette-forming glioneuronal tumor of the fourth ventricle with a positive isocitrate dehydrogenase 1 mutation, progressed to glioblastoma after 6 years from diagnosis. We discuss the clinical history, radiological findings, and histopathological characteristic with immunohistochemistry findings observed in this unique case. Conclusions: Despite being acceptable as benign, based on our observations in this case, there is a potential for malignant transformation of rosette-forming glioneuronal tumor. The role of isocitrate dehydrogenase 1 mutation leading to malignant transformation could not be established as our finding is novel and further prospective studies are required to prove this association. Key words: Glioblastoma IDH mutant, IDH 1 mutation, Malignant transformation, RGNT |
url |
http://www.sciencedirect.com/science/article/pii/S2590139718300061 |
work_keys_str_mv |
AT ronieromeleanjayapalan malignanttransformationofarosetteformingglioneuronaltumorwithidh1mutationacasereportandliteraturereview AT keinseongmun malignanttransformationofarosetteformingglioneuronaltumorwithidh1mutationacasereportandliteraturereview AT kumthongwong malignanttransformationofarosetteformingglioneuronaltumorwithidh1mutationacasereportandliteraturereview AT sheaufungsia malignanttransformationofarosetteformingglioneuronaltumorwithidh1mutationacasereportandliteraturereview |
_version_ |
1724906859342594048 |